1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
(2025) In Nature Cancer
- Contribution to journal › Article
- 2024
-
Mark
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases
- Contribution to journal › Article
-
Mark
TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
- Contribution to journal › Article
-
Mark
Precision Diagnostics in Myeloid Malignancies : Development and Validation of a National Capture-Based Gene Panel
- Contribution to journal › Article
-
Mark
Micro-costing of genetic diagnostics in acute leukemia in Sweden : from standard-of-care to whole-genome sequencing
- Contribution to journal › Article
- 2023
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
- Contribution to journal › Article
-
Mark
Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
- Contribution to journal › Article
- 2022
-
Mark
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia
- Contribution to journal › Article
-
Mark
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
- Contribution to journal › Article
